Real-world data, theoretical application of guidelines, cost, and access: How do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?

Authors

Christie M. Ballantyne, Baylor College of Medicine, USA.
Salim S. Virani, Baylor College of Medicine, USA.Follow

Document Type

Editorial

Department

Office of the Provost; Cardiology

Comments

This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

European Heart Journal

DOI

10.1093/eurheartj/ehaa139

Recommended Citation

Ballantyne, C. M., Virani, S. S. (2020). Real-world data, theoretical application of guidelines, cost, and access: How do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?. European Heart Journal, 41(40), 3910-3912.
Available at: https://ecommons.aku.edu/provost_office/569